Insider · CIK 0001891104
Yale Podnos
officer
Files at STLN (Oncology Institute, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 20, 2024 | STLN Oncology Institute, Inc. | DDisposition to issuer Common stock | -1,709 | $0.14 | $232 | 74,261 | Nov 21, 2024 |
| Nov 20, 2024 | STLN Oncology Institute, Inc. | DDisposition to issuer Common stock | -267 | $0.14 | $36 | 73,994 | Nov 21, 2024 |
| Nov 20, 2024 | STLN Oncology Institute, Inc. | DDisposition to issuer Common stock | -1,026 | $0.14 | $140 | 72,968 | Nov 21, 2024 |
| Nov 12, 2024 | STLN Oncology Institute, Inc. | JOther Common stock | -11,359 | $0.00 | $0 | 93,009 | Nov 18, 2024 |
| Nov 12, 2024 | STLN Oncology Institute, Inc. | JOther Common stock | -17,039 | $0.00 | $0 | 75,970 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.